Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewAdvanced techniques to study intracellular nanoparticle trafficking
Dr María Navalón recently defended her doctoral thesis at IQS, in which she developed and perfected advanced microscopy methods to understand the behaviour of nanoparticles in the field of
-
New#NewAseBioMember|"AseBio is the meeting point of the biotech sector in Spain, a space to c...
Meet our new member SmartBio Analytics. Meet our new member Rafael Terán, General Manager.
-
NewMicrobial diversity of traditional Ethiopian foods
Traditional fermented foods and beverages play a vital role in the diets of millions around the world, especially in developing countries.
-
CompanyIBERANIA
-
NewORYZON announces submission of Phase III protocol to FDA to initiate PORTICO-2 trial of v...
PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients.
-
NewAseBio presents its proposals to the European Commission for the future Biotech Act
Our contribution addresses the sector’s main challenges with proposals focused on three pillars: agile funding for innovation, simpler and faster regulation, and a more cohesive and globally
-
Press releaseAseBio presents its proposals to the European Commission for the future Biotech Act
We warmly welcome this initiative, convinced that a solid legislative framework is essential to unlocking the full potential of biotechnology for the benefit of the economy, society, and Europe’s
-
NewGENESIS Biomed participated in the valuation of CellsIA, a company acquired by Laboratorio...
GENESIS Biomed provides specialised services in the valuation and search for licensees or acquirers for biomedical projects.
-
NewBeCytes opens new laboratory to accelerate the production of in vitro cellular models
BeCytes Biotechnologies, a company specialized in the research and development of in vitro cellular models, has launched a new laboratory at the Barcelona Science Park (PCB) to expand its production
-
EventBIO-EUROPE SPRING 2026
-
-
NewORYZON to attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-...
Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27.
-
AllyIMCD España Especialidades Químicas, S.A
IMCD es un distribuidor y formulador líder de productos químicos e ingredientes especializados. Aportamos innovación para un mundo más saludable al proporcionar materiales y excipientes con una cadena
-
New#NewAseBioMember| "We also see AseBio as an opportunity to stay aligned with regulatory, s...
Meet our new member Disrupt Therapeutics. We spoke with Patrick Tresserras, CEO y Maria Gallo COO de Disrupt Therapeutics
-
New#NewAseBioMember | "We see AseBio as the go-to platform for fostering synergies within Spa...
Meet our new member Nuage. We spoke with Stuart Hughes, CEO
-
New#NewAseBioMember | “AseBio is a key platform that brings together the main players in the ...
Meet our new member Melius Organics. We spoke with Jordi Mestre, CEO & Cofundador.
-
-
NewR&D investment in the biotech sector grows by 5.2% to 1,282 million euros
In 2023, the activity of biotech companies in Spain generated more than 13,000 million euros of income, which represents 1.1% of the national GDP.
-
Press release
R&D investment in the biotech sector grows by 5.2% to 1,282 million euros
In 2023, the activity of biotech companies in Spain generated more than 13,000 million euros of income, which represents 1.1% of the national GDP. After an exceptional 2023 for the sector in terms of
-
New#NewAseBioMember | “Being a member of AseBio represents a great opportunity to increase ou...
Meet our new member Airway Shield. We spoke with Julio Alonso Babarro, CEO.
-
NewAbilityPharma’s IBRILATAZAR (ABTL0812) doubles overall survival in patients with squamous ...
These results support ibrilatazar as a potential backbone therapy for patients with one of the most common subtypes of lung cancer worldwide, addressing a high- unmet need.
